• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Central America Pharmaceuticals and Healthcare Report Q1 2013 - Product Image

Central America Pharmaceuticals and Healthcare Report Q1 2013

  • Published: January 2013
  • Region: America, Central America
  • 55 pages
  • Business Monitor International

FEATURED COMPANIES

  • Ancalmo Internacional
  • Company Profiles
  • Donovan Werke
  • MORE

BMI View: The political instability and underdeveloped economies in many Central American countries make the region less attractive to multinationals, compared with most neighbouring countries. However,
the heavy reliance on imported medicine in the region provides revenue-generating opportunities for generic drugmakers from neighbouring Latin American countries and India. We highlight that Costa Rica and Panama can be the premier countries in the region for foreign drugmakers to expand their presence.

Headline Expenditure Projections

- Pharmaceuticals: US$3.3bn in 2011 to US$3.5bn in 2012; +5.5% in US dollar terms. Our forecast has been revised slightly upwards since Q412 due to improved historical data.

- Healthcare: US$13.51bn in 2011 to US$14.68bn in 2012; +8.6% in US dollar terms. Our forecast has been revised upwards since Q412 due to improved macroeconomic factors.

Risk/Reward Ratings

In BMI's Q113 Pharmaceutical Risk/Reward Ratings (RRRs), based on our analysis and assessment of the market's appeal to pharmaceutical companies, the Americas region continues to rank second lowest globally with a score of 49.4 out of 100; behind Western Europe READ MORE >

Executive Summary 5

SWOT Analysis 7

Central America Pharmaceuticals And Healthcare SWOT 7

Central America Political SWOT 8

Central America Economic SWOT 8

Pharmaceutical Risk/Reward Ratings 9
Table: Americas Pharmaceutical Risk/Reward Ratings, Q113 9

Regulatory Regime 10

Intellectual Property Regime 11

Costa Rica 11

El Salvador 12

Honduras 12

Nicaragua 13

Panama 13

Guatemala 13

Industry Developments 14

Regional Developments 14

Guatemala 14

Costa Rica 16

El Salvador 18

Panama 20

Honduras 20

Nicaragua 21

Belize 22

Industry Trends And Developments 24

Epidemiology 24

Clinical Trials Sector 25

Guatemala 26

Costa Rica 26

El Salvador 26

Panama 26

Honduras 26

Nicaragua 27

Belize 27

Industry Forecast Scenario 28

Overall Market Forecast 28
Table: Pharmaceutical Sales Indicators 2008-2016 29

Guatemala 29

Costa Rica 29
Table: Incentives In The Free Trade Zone In Costa Rica 31

El Salvador 31

Honduras 32

Panama 32

Nicaragua 32

Belize 33

Key Growth Factors - Industry 34

Guatemala 34

Costa Rica 34

El Salvador 35

Panama 35

Honduras 36

Nicaragua 36

Belize 36

Key Growth Factors - Macroeconomic 37

Pharmaceutical Trade Forecast 42
Table: Exports And Imports Indicators 2008-2016 43

Guatemala 43

Costa Rica 43

El Salvador 44

Panama 44

Honduras 44

Nicaragua 45

Belize 45

Competitive Landscape 46

Company Profiles 47

Ancalmo Internacional 47

Donovan Werke 48

Glossary 49

BMI Methodology 51

How We Generate Our Pharmaceutical Industry Forecasts 51

Pharmaceutical Risk/Reward Ratings Methodology 52

Ratings Overview 52
Table: Pharmaceutical Risk/Reward Indicators 53

Weighting 54
Table: Weighting Of Components 54

Sources 54

Company Profiles
Ancalmo Internacional
Donovan Werke

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos